• Extranodal natural killer/T-cell lymphoma (ENKTCL), nasal type rarely involves the orbital/ocular adnexal tissue.
Introduction
Extranodal natural killer/T-cell lymphoma (ENKTCL), nasal type is a rare but aggressive malignant neoplasm that typically arises in the paranasal sinuses or nasal cavity [1] , but has also been documented in the skin and soft tissue, upper respiratory and gastrointestinal tracts, and testes [2] . Like other non-Hodgkin lymphomas, it can masquerade as an intraocular inflammatory or infectious process [3] , which can lead to delayed diagnosis and vision loss. The prognosis for ENKTCL is substantially worse than that of other T-cell or B-cell lymphomas [4] , especially if patients present late or if there is orbital or ocular adnexal involvement [2, 5] . Early diagnosis is thus of utmost importance, but can prove quite challenging. Previous studies have documented orbital/ocular adnexal involvement of ENKTCL, both as a primary [5] [6] [7] [8] [9] [10] and secondary [4, [10] [11] [12] [13] manifestation of the disease. Intraocular involvement is quite rare with only a small number of published cases [4, [14] [15] [16] . To our knowledge, we are the first to report a case of ENKTCL metastatic to the space beneath the retinal pigment epithelium (RPE). The case is also remarkable for a coincident paraneoplastic lymphoma-associated retinopathy associated with anti-retinal autoantibodies to glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Case Report
A 53-year-old African American man experienced gradual onset of photopsia and floaters in both eyes during the preceding year. Four months prior to presentation, he noticed a dramatic, painless decline in his vision over several weeks. An outside ophthalmologist documented his visual acuity at 20/400 on the right and hand motion on the left, while his intraocular pressure was 17 mm Hg in both eyes. His external examination and extraocular movements were normal. Fine inferior keratic precipitates and rare cells were seen in the anterior chamber and vitreous, along with 2+ nuclear sclerotic cataracts in both eyes. Dilated fundus examination revealed bilateral multifocal chorioretinal pigmentary changes with macular serous pigment epithelial detachments and inferior exudative retinal detachments.
Systemic workup for infectious and inflammatory etiologies of possible panuveitis with chorioretinitis at an outside hospital was negative for Bartonella spp., Lyme disease, cytomegalovirus, Epstein-Barr virus (EBV), toxoplasmosis, Tropheryma whipplei, human immunodeficiency virus, tuberculosis, and sarcoidosis. He was hypotensive and short of breath, and an echocardiogram revealed cardiac tamponade requiring pericardiocentesis. Flow cytometry of the pericardial fluid demonstrated a population of lymphocytes strongly positive for CD3, CD56, and CD7 markers, but with weak expression of CD2, loss of CD5, and no expression of CD4, CD8, or T-cell receptors alpha/beta and gamma/delta. A computed tomography scan of the head did not reveal any intracranial, nasal, or paranasal sinus lesions. A positron emission tomography/computed tomography scan showed nonspecific fluorodeoxyglucose activity in the hilar and mediastinal lymph nodes. Our patient was treated for peripheral T-cell lymphoma with EPOCH (etoposide, prednisolone, Oncovin [vincristine], cyclophosphamide, hydroxydaunorubicin).
After two cycles of chemotherapy, the patient developed altered mental status, hypotension, and fevers. Blood and cerebral spinal fluid cultures showed no growth, and cerebral spinal fluid tests for venereal disease research laboratory, cryptococcal antigen, herpes simplex virus antibody, and cytology were negative. He was started on empiric broad-spectrum antimicrobial coverage and transferred to Duke University Hospital's intensive care unit. Ophthalmology evaluation in the intensive care unit found that he was unable to perceive light in either eye. Large, bilateral, multifocal, subretinal infiltrates and masses with overlying serous retinal detachments and mild vitreous opacities were noted in the posterior pole and midperiphery. Arteriolar narrowing and patches of atrophic RPE in regions of attached retina were also present. The optic nerves appeared normal, and magnetic resonance imaging of the brain and orbits without contrast confirmed symmetric optic nerves of normal signal intensity without evidence of orbital, nasal, paranasal sinus, or intracranial involvement. The patient quickly became hemodynamically unstable and expired upon transitioning to comfort measures. Autopsy revealed disseminated lymphoma involving the heart, right lung, and two subcarinal lymph nodes focally. Lymphoma was absent in paraaortic and paratracheal lymph nodes. The nasal cavity and paranasal sinuses were not examined due to the potential for disfigurement.
Horizontal sectioning of the right eye revealed a flocculent white mass beneath the RPE (Fig. 1a) and a large circular region of hypopigmentation with patchy stippled melanin pigmentation of the neurosensory retina just nasal to the optic disc (Fig. 1b) . The RPE overlying the white tumor was stippled (Fig. 1c) . Regions of atrophic neurosensory retina also existed in regions where subretinal tumor was notably absent (Fig. 1d ). There was no gross evidence of tumor invasion of the choroid, ciliary body, iris, or optic nerve. Similar findings were present in the left eye.
Microscopic examination revealed multifocal lymphoma with extensive tumor necrosis localized beneath the neurosensory retina and RPE of both eyes (Fig. 2a) . Tumor cells were mostly medium-sized or larger pleomorphic cells with prominent nucleoli (Fig. 2b) . Larger cells were often multinucleated. Extensive, patchy loss of RPE cells was associated with degeneration of the overlying photoreceptors and outer nuclear layer. RPE and photoreceptor/ outer nuclear layer degeneration existed not only in areas with un- derlying sub-RPE lymphoma (Fig. 2c) , but also in regions that lacked lymphomatous infiltrates (Fig. 2d) . Tumor cells had the following immunophenotype, with the estimated percentage of cells staining positively in parentheses: CD3 (> 99%; Fig. 3a) , granzyme B (> 99%; Fig. 3b ), TIA-1 (> 99%; Fig. 3c ), CD30 (90%), CD56 (80-90%; Fig. 3d ), CD7 (90-95%; Fig. 3e ), CD20 (30-40%), MUM1 (5%), CD5 (< 5%), CD8 (< 5%), and CD2 (< 5%). Lymphoma cells did not express CD4, PAX-5, CD79a, CD138, anaplastic lymphoma kinase 1, or human herpes virus 8. Epstein-Barr encoding region in situ hybridization was also positive in all nonnecrotic tumor cells (Fig. 3f) . The diagnosis was ENKTCL, nasal type in both eyes. Bilateral loss of RPE/photoreceptors in areas devoid of lymphoma was interpreted as lymphoma-associated retinopathy, and subsequent Western blot analysis of postmortem blood (Ocular Immunology Laboratory, Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA) revealed anti-retinal autoantibodies against the 36-kD GAPDH protein, but no marked immunohistochemical staining of human retina.
Discussion
According to the 2017 World Health Organization classification system, natural killer/T-cell lymphoma, nasal type is a rare, extranodal lymphoma derived from cytotoxic T cells or natural killer cells [1] . It commonly presents in adult men, especially in Asia and Central America, but there are infrequent reports of cases in Europe and the USA [17] . Seventy to ninety percent of ENKTCLs originate in the nasopharynx, although disseminated and extranasal disease also occurs [2, 3, 12, 18] , as it did in our patient. This malignancy is characterized by an aggressive angiodestructive growth pattern and tumor necrosis [18] as well as a pathogenic link to EBV [19] [20] [21] [22] . In our patient, the histologic appearance of the lymphomatous infiltrates and the expression of EBV by in situ hybridization helped us to confirm the diagnosis of ENKTCL, nasal type [18] . In addition, the lymphoma cells uniformly expressed the T-cell marker CD3 and the cytotoxic granule-associated proteins granzyme B and TIA-1, and a majority of the cells were positive for CD7 and CD30. Approximately 80-90% of the cells expressed CD56, which helped to distinguish this case from EBV-positive anaplastic large-cell lymphoma, which should have only a subset of lymphoma cells weakly expressing CD56 [23] . Flow cytometry analysis of tumor cells in pericardial fluid lacked expression of T-cell receptors alpha/beta and gamma/delta, ruling out the possibility of a gamma-delta T-cell lymphoma such as has been described recently as a presenting cause of vison loss [24] . In addition, gamma-delta T-cell lymphomas are typically negative for EBV-encoded RNA [25] . Our patient was unusual in that the metastases to the eyes were intraocular and did not originate in the nasal cavity or paranasal sinuses. In general, metastases to the eye and ocular adnexa from T-cell lymphomas are uncommon compared to B-cell lymphomas [11, [26] [27] [28] . Orbital/ocular adnexal involvement in the nasal type of ENKTCL is usually secondary to invasion from the adjacent nasopharynx [4, [10] [11] [12] [13] . In the largest available retrospective review of patients with ENKTCL, nasal type, 9.6% of 115 subjects had secondary ocular invasion, though it was not specified whether the invasion was orbital, intraocular, or both [13] . Orbital/ocular adnexal involvement of ENKTCL in the absence of nasal/sinus disease is extremely uncommon, with only 13 reported cases in the literature [5] [6] [7] [8] [9] [10] . Intraocular ENKTCL has also been reported rarely [4, [14] [15] [16] . In a series of 24 cases with nasal and paranasal sinus ENKTCL, 6 patients experienced vision-threatening ocular complications ranging from uveitis and vitritis to orbital involvement [12] . In one published case of nasal ENKTCL, vitritis improved following intrathecal chemotherapy and intravitreal methotrexate; however, there were no uveoretinal lesions noted on the dilated fundus examination [15] . Another patient with intraocular ENKTCL was treated with methylprednisolone for presumed optic neuritis due to optic nerve edema; autopsy subsequently revealed posterior optic nerve invasion by the tumor [3] . Cimino et al. [4] reported a patient with nasal type ENKTCL who developed vitritis and retinochoroidal lesions. Diagnostic vitrectomy confirmed the diagnosis of intraocular spread of the lymphoma, but the histopathology of the retina and choroid was not examined.
To our knowledge, we are the first to document the histopathologic findings of ENKTCL metastatic to the subretinal space. In our patient, the lymphoma masqueraded clinically as panuveitis with chorioretinitis. Unlike B-cell lymphomas, which tend to metastasize to the uvea by hematogenous spread [27, 29] , our patient did not have any lymphomatous infiltrate within the choroid, iris, or ciliary body. Rather, the natural killer/T-cell lymphoma metastases were confined to the space beneath the neurosensory retina and between the RPE and the Bruch membrane. This finding is similar to those of other types of T-cell lymphoma, which have a predilection for invasion of the vitreous and retina, sparing the choroid [27] .
We are also the first to report an association of ENKTCL with anti-retinal autoantibodies to GAPDH along with histopathologic findings supporting lymphoma-associated retinopathy. Our patient's examination findings of attenuated vessels with patchy RPE changes, as well as extensive loss of RPE cells and photoreceptors on histopathology, are typical of cancer-associated retinopathy/lymphoma-associated retinopathy [30] [31] [32] . GAPDH plays a central role in photoreceptor cell glycolysis and is the second most common antigenic target in autoimmune retinal diseases [33, 34] . Although cancerassociated retinopathy has been widely documented in patients with solid tumors of the breast, lung, and gynecologic system [35] , reports of hematologic malignancies are quite rare [36, 37] . In one case of lymphoma-associated retinopathy, serum antibodies against a 47-kD retinal protein were detected in a patient with follicular cell lymphoma [36] , while antibodies to a 65-kD retinal protein were reported in Hodgkin lymphoma [37] . Given the clinical course and histopathologic findings in our patient, we believe that his rapid and complete vision loss was multifactorial, resulting not only from retinal degeneration overlying the sub-neurosensory retina and the sub-RPE lymphoma, but also from a lymphoma-related paraneoplastic retinopathy that obliterated the RPE and photoreceptors throughout the remaining, otherwise attached, peripheral retina. Our case should however be interpreted with a caveat. Since there was no marked immunohistochemical staining of retinal tissue using postmortem blood, the anti-GAPDH autoantibodies might not have been pathogenic to the retina and may have been nonspecifically present in the serum.
The prognosis of ENKTCL is poor, with a 5-year cumulative survival ranging from 37.9 to 45.5% and a median survival approximated at 12.5 months [2, 10, 12, 18] . While early stages may respond to radiation therapy, most patients present late and will fail multimodal treatment with chemotherapy and adjuvant radiation [2, 5, 7, 8, 10, 13] . Orbital/ocular adnexal involvement may portend an even worse outcome. In one review of 9 cases of primary orbital ENKTCL, the median survival was a mere 4 months [5] . Our patient had widespread systemic and intraocular disease at the time of initial presentation, and he declined within 3 months despite aggressive chemotherapy and intensive care management. Patients with ENKTCL should be referred to an ophthalmologist to evaluate for intraocular and periocular involvement, including any evidence of lymphoma-associated retinopathy, as such findings may portend a poor prognosis.
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